Uncategorised - European Medical Journal

Infectious Disease Diagnostics: Superbugs, Zoonotic Threats, and the Next Pandemic

Explore diagnostic innovations in the fight against antimicrobial resistance, gaps in zoonotic disease detection, and more

Seasonal Immunotherapy: Safe to Start During Pollen Peaks?

The study suggests that initiating Artemisia annua SLIT during the pollen season is just as safe and well-tolerated as starting it before.

24 Apr 2025

Case Report of a Patient Presenting with Acute Flank Pain

A female in her 40s, with a history of heavy smoking presented to the emergency department with a 6-hour history of paraesthesia and…

FMT at Home Cuts CDI Hospitalization Time

Clostridioides difficile infection (CDI) remains a pressing challenge in older adults, particularly those with comorbidities, leading to significant mortality and healthcare costs.

Multimorbidity in Systemic Sclerosis: Hidden Driver of Poor Outcomes

Multimorbidity, the presence of multiple co-existing health conditions, has emerged as a critical factor influencing survival and physical function in patients with systemic sclerosis (SSc), according to a large cohort study of 2,000 participants.

Probiotics Improve Liver Function During Chemotherapy

A recent study explored the combined impact of oral nutritional supplementation and probiotics on gut microbiota and liver function.

Biomimetic Hydrogels Revolutionise CAR T Cancer Therapy Production

Biomimetic hydrogels boost CAR T cell production by 50%, cutting cancer therapy costs.

Caffeine Could Help Reduce Cardiovascular Risk in Lupus

A study finds that caffeine intake improves endothelial function in systemic lupus erythematosus by enhancing cell survival and reducing inflammation.

Breakthrough Study Links Parasitic Infection to Cervical Cancer Risk

Research presented at ESCMID Global 2025 reveals how Schistosoma haematobium infection and praziquantel treatment may trigger gene activity linked to cervical cancer risk in women.

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies targeting ALT-positive cancers.